Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice. | Mol Genet Metab Rep | 2024 | 39257531 | PubTator, text mining | PubMed |
| Programming DNA Nanoassemblies into Polyvalent Lysosomal Degraders for Potent Degradation of Pathogenic Membrane Proteins. | Nano Lett | 2024 | 39225423 | PubTator, text mining | PubMed |
| Global microRNA profiling of bone marrow-MSC derived extracellular vesicles identifies miRNAs associated with hematopoietic dysfunction in aplastic anemia. | Sci Rep | 2024 | 39179703 | PubTator, text mining | PubMed |
| Lysophosphatidic acid improves development of porcine somatic cell nuclear transfer embryos. | J Anim Sci Technol | 2024 | 39165747 | PubTator, text mining | PubMed |
| SNX32 Regulates Sorting and Trafficking of Activated EGFR to the Lysosomal Degradation Pathway. | Traffic | 2024 | 39073202 | PubTator, text mining | PubMed |
| Target repositioning using multi-layer networks and machine learning: The case of prostate cancer. | Comput Struct Biotechnol J | 2024 | 38983753 | PubTator, text mining | PubMed |
| Ubiquitin recruiting chimera: more than just a PROTAC. | Biol Direct | 2024 | 38978100 | PubTator, text mining | PubMed |
| Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons. | Neuropharmacology | 2024 | 38972371 | PubTator, text mining | PubMed |
| Lysosome-Targeting Bacterial Outer Membrane Vesicles for Tumor Specific Degradation of PD-L1. | Small | 2024 | 38934533 | PubTator, text mining | PubMed |
| Polygenic subtype identified in ACCORD trial displays a favorable type 2 diabetes phenotype in the UKBiobank population. | Hum Genomics | 2024 | 38909264 | PubTator, text mining | PubMed |
| Molecular pharmacology and therapeutic advances of monoterpene perillyl alcohol. | Phytomedicine | 2024 | 38897045 | PubTator, text mining | PubMed |
| Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities. | Front Endocrinol (Lausanne) | 2024 | 38872970 | PubTator, text mining | PubMed |
| Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy. | Neuro Oncol | 2024 | 38853689 | PubTator, text mining | PubMed |
| Expanding the horizons of targeted protein degradation: A non-small molecule perspective. | Acta Pharm Sin B | 2024 | 38828146 | PubTator, text mining | PubMed |
| Integrative analysis of Iso-Seq and RNA-seq data reveals transcriptome complexity and differential isoform in skin tissues of different hair length Yak. | BMC Genomics | 2024 | 38773419 | PubTator, text mining | PubMed |
| Response to Comments on "Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice". | J Pharmacol Exp Ther | 2024 | 38772716 | PubTator, text mining | PubMed |
| Impairing hydrolase transport machinery prevents human melanoma metastasis. | Commun Biol | 2024 | 38750105 | PubTator, text mining | PubMed |
| CD8α-CI-M6PR Particle Motility Assay to Study the Retrograde Motion of CI-M6PR Receptors in Cultured Living Cells. | Bio Protoc | 2024 | 38737505 | PubTator, text mining | PubMed |
| Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma. | Nucl Med Biol | 2024 | 38718557 | PubTator, text mining | PubMed |
| The associations of IGF2, IGF2R and IGF2BP2 gene polymorphisms with gestational diabetes mellitus: A case-control study. | PLoS One | 2024 | 38701040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=8